Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - BIOANALYTICAL SYSTEMS INCtv481504_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - BIOANALYTICAL SYSTEMS INCtv481504_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - BIOANALYTICAL SYSTEMS INCtv481504_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - BIOANALYTICAL SYSTEMS INCtv481504_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - BIOANALYTICAL SYSTEMS INCtv481504_ex21-1.htm
EX-10.5 - EXHIBIT 10.5 - BIOANALYTICAL SYSTEMS INCtv481504_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - BIOANALYTICAL SYSTEMS INCtv481504_ex10-4.htm
10-K - 10-K - BIOANALYTICAL SYSTEMS INCtv481504_10k.htm

 

Exhibit 32.1

 

Certifications of Acting Principal Executive Officer

 

Pursuant to Section 906

 

Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

 

The undersigned, the Acting Principal Executive Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of his knowledge:

 

(a)the Form 10-K Annual Report of the Company for the fiscal year ended September 30, 2017 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

  By:  /s/  Philip A. Downing
  Philip A. Downing
  Acting Principal Executive Officer
  Date:   December 22, 2017